Literature DB >> 2663606

Immunohistochemical study of carbohydrate antigen expression in gastric carcinoma.

T Dohi1, K Abe, S Ohshiba.   

Abstract

The expression of carbohydrate antigens in malignant and non-malignant gastric mucosa was studied immunohistochemically using the monoclonal antibody AH6 directed to Ley antigen, FH2 directed to Lex antigen, and FH6 directed to sialyl-Lex antigen. Formalin-fixed gastric tissue resected from 54 patients with gastric cancer and 20 patients with gastric ulcer were tested. The incidence of positive cases in gastric cancer patients with each antibody was as follows: AH6;85%, FH2;74%, FH6;74%. The Lex antigen was expressed in 81.5% of cases histologically classified as undifferentiated type, and 66.7% of cases classified as differentiated type. It was expressed in a higher incidence in early stage cancer (93.3%) than in advanced stage cancer (66.7%). Sialyl-Lex antigen was detected in more cases of differentiated type (88.9%) than in those of undifferentiated type (59.3%), whereas none of 8 early cancers of undifferentiated type expressed the antigen. The incidence of the expression of Ley antigen did not differ in relation to histological type or invasiveness. Lex and Ley antigens were detected in noncancerous gastric epithelium. Sialyl-Lex antigen was not detected in the normal fundic gland region. These results demonstrate that Lex antigen may be a differentiation-associated antigen, and sialyl-Lex antigen might be useful as a marker of differentiated cancer and an indication for invasion of undifferentiated cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2663606     DOI: 10.1007/bf02774320

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  22 in total

1.  Precancerous lesions of upper gastrointestinal tract.

Authors:  B C MORSON
Journal:  JAMA       Date:  1962-02-03       Impact factor: 56.272

2.  Lex and Ley antigen expression in human pancreatic cancer.

Authors:  Y S Kim; S H Itzkowitz; M Yuan; Y Chung; K Satake; K Umeyama; S Hakomori
Journal:  Cancer Res       Date:  1988-01-15       Impact factor: 12.701

Review 3.  Philip Levine award lecture: blood group glycolipid antigens and their modifications as human cancer antigens.

Authors:  S Hakomori
Journal:  Am J Clin Pathol       Date:  1984-12       Impact factor: 2.493

4.  Characterization of sialosylated Lewisx as a new tumor-associated antigen.

Authors:  K Fukushima; M Hirota; P I Terasaki; A Wakisaka; H Togashi; D Chia; N Suyama; Y Fukushi; E Nudelman; S Hakomori
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

5.  Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6).

Authors:  Y Fukushi; E Nudelman; S B Levery; S Hakomori; H Rauvala
Journal:  J Biol Chem       Date:  1984-08-25       Impact factor: 5.157

6.  A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1.

Authors:  R Kannagi; E Nudelman; S B Levery; S Hakomori
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

7.  Location and distribution of difucoganglioside (VI3NeuAcV3III3Fuc2nLc6) in normal and tumor tissues defined by its monoclonal antibody FH6.

Authors:  Y Fukushi; R Kannagi; S Hakomori; T Shepard; B G Kulander; J W Singer
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

8.  Lewis blood group fucolipids and their isomers from human and canine intestine.

Authors:  J M McKibbin; W A Spencer; E L Smith; J E Mansson; K A Karlsson; B E Samuelsson; Y T Li; S C Li
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

9.  Immunohistochemical localization of Y hapten and the structurally related H type-2 blood-group antigen on large-bowel tumours and normal adult tissues.

Authors:  A Brown; I O Ellis; M J Embleton; R W Baldwin; D R Turner; J D Hardcastle
Journal:  Int J Cancer       Date:  1984-06-15       Impact factor: 7.396

10.  Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain.

Authors:  Y Fukushi; S Hakomori; E Nudelman; N Cochran
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

View more
  2 in total

1.  Fucosyltransferase-4 and Oligosaccharide Lewis Y Antigen as potentially Correlative Biomarkers of Helicobacter pylori CagA Associated Gastric Cancer.

Authors:  Faisal Aziz; Wei Gao; Qiu Yan
Journal:  Pathol Oncol Res       Date:  2016-10-18       Impact factor: 3.201

2.  Clinicopathologic significance of sialyl Le(x) expression in advanced gastric carcinoma.

Authors:  N Futamura; S Nakamura; M Tatematsu; Y Yamamura; R Kannagi; H Hirose
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.